Brevan Howard Capital Management LP Ionis Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,924 shares of IONS stock, worth $224,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,924Holding current value
$224,534% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
397Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$612 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$607 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$446 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$378 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$260 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.47B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...